Forest CEO: Aptalis a `Compelling Opportunity'

Forest CEO: Aptalis a `Compelling Opportunity' Play

Jan. 8 (Bloomberg) -- Brent Saunders, chief executive officer of Forest Laboratories Inc., talks about the company's agreement to acquire Aptalis Pharma for $2.9 billion in cash. Aptalis is a closely held company whose shareholders include investment firm TPG Capital. Saunders speaks with Betty Liu on Bloomberg Television's "In the Loop." (Source: Bloomberg)

  • On Air Now

    PAID PROGRAMMING Watch Now

  • Next

    BRINK: Aquapods, Volkswagen, Palomar Medical Ctr

blog comments powered by Disqus